Skip to content
healthcare.dev

PINRID

NDC 73581-113, Pyrantel Pamoate, tablet, from YYBA CORP.

Product NDC
73581-113
Status
Listed
Labeler
YYBA CORP
Dosage form
TABLET
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M024
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/73581-113 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PYRANTEL PAMOATE250 mg/1
Package NDCNDC-11Package
73581-113-01735810113011 TABLET in 1 BOTTLE (73581-113-01)
73581-113-06735810113066 TABLET in 1 BOTTLE (73581-113-06)
73581-113-127358101131212 TABLET in 1 BOTTLE (73581-113-12)
73581-113-247358101132424 TABLET in 1 BOTTLE (73581-113-24)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 73581-113 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/73581-113 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 73581-113. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.